Skip to main content Skip to local navigation
Home » Posts tagged 'The Globe and Mail'

The Globe and Mail

Professor Robert MacDermid shares last-minute insight on interpreting polls

Elections Canada requires the publishers of public opinion surveys during elections to publish some facts about the methodology, so readers can gauge how reliable the poll is, wrote Global Television News online April 28: Anyone transmitting the results of a poll has to include the name of the sponsor and the company that did the […]

Professor Rod MacRae co-authors study that finds organic farms are more energy efficient

Organic farms can be more energy efficient than conventional farms that mass produce crops using unsustainable practices, a surprising result from a study co-authored by a York University professor. Researchers analyzed 130 studies to compare the energy use and global warming potential of organic versus conventional farming. They concluded that organic farms were more energy […]

Professor and CRC Leo Panitch on renewed interest in Karl Marx

With the West suffering from the after-effects of the financial crisis and revolution in the air in parts of the world, could it possibly be springtime for Marx? wrote The Globe and Mail March 26: "I'm optimistic about the explosion that's happened in Wisconsin," says Leo Panitch, a political science professor at York University [Faculty […]

Professor Joel Lexchin co-authors study on free journals and costly or problematic drugs

Medical publications distributed freely to health professionals often promote drugs that are costly or have potential problems, says a new study warning that such practices could influence which drugs doctors prescribe, wrote The Globe and Mail Feb. 28: Unlike medical publications that require paid subscriptions, free journals get most or all of their funding from […]

Professor Joel Lexchin: Health Canada should beef up drug-monitoring system

Health Canada did not pull a pain drug off the market until US officials made the decision to recall it, a move sparking criticism of the government's ability to act independently to protect the safety of Canadians from potentially dangerous medications, reported The Globe and Mail Dec. 3: Health Canada and Paladin Labs Inc. announced […]